Cargando…
Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery
Organoids serve as a novel tool for disease modeling in three-dimensional multicellular contexts. Static organoids, however, lack the requisite biophysical microenvironment such as fluid flow, limiting their ability to faithfully recapitulate disease pathology. Here, we unite organoids with organ-on...
Autores principales: | Hiratsuka, Ken, Miyoshi, Tomoya, Kroll, Katharina T., Gupta, Navin R., Valerius, M. Todd, Ferrante, Thomas, Yamashita, Michifumi, Lewis, Jennifer A., Morizane, Ryuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491724/ https://www.ncbi.nlm.nih.gov/pubmed/36129975 http://dx.doi.org/10.1126/sciadv.abq0866 |
Ejemplares similares
-
Mechanosensation in leaf veins
por: Yang, Tsu-Hao, et al.
Publicado: (2023) -
JAG1-NOTCH4 mechanosensing drives atherosclerosis
por: Souilhol, Celine, et al.
Publicado: (2022) -
Personalized chordoma organoids for drug discovery studies
por: Al Shihabi, Ahmad, et al.
Publicado: (2022) -
Cell disorientation by loss of SHH-dependent mechanosensation causes cyclopia
por: Ohtsuka, Daisuke, et al.
Publicado: (2022) -
Flow-enhanced vascularization and maturation of kidney organoids in vitro
por: Homan, Kimberly A., et al.
Publicado: (2019)